The global antimalarial drugs market size, valued at USD 1.13 billion in 2024, is projected to reach USD 1.19 billion in 2025 and USD 1.75 billion by 2035, representing a CAGR of 3.9% during the forecast period. The antimalarial drug industry is constantly witnessing an upward trajectory as players are focusing on the development of resistance-free antimalarial drugs to mitigate the concern of drug resistance. A recent success in antimalarial drugs has been shared by the Karine Le Roche, (profes...

Major players like AstraZeneca (UK), Pfizer (US), Merck (US), and Roche (Switzerland) are making significant investments to achieve sustainability goals and reduce their environmental impact. They are adopting strategies such as green chemistry, renewable energy integration, and upgrading manufacturing facilities.Roche (Switzerland) has committed a massive investment of USD 50 billion over five years into its US pharmaceutical and diagnostics operations. This investment includes expanding and up...

The probiotics market, valued at USD 70.9 billion in 2024, is project to reach USD 76.2 billion in 2025 and USD 165.1 billion by 2035, representing a CAGR of 8.0% during the forecast period 2025 to 2035. In terms of type of product, the food and beverages segment holds the highest share (nearly 80%) of the market.  The nutritional supplements segment is capturing the majority of the market share (~60%) in the year 2025, with respect to type of probiotic dietary supplement segment. In terms o...

The NGS-based RNA-sequencing market is estimated to grow from USD 3.59 billion in 2024 to reach USD 4.41 billion in 2025 and USD 22.44 billion by 2035, representing a CAGR of 17.7% during the forecast period. According to our NGS-based RNA-sequencing market report, presently, the consumables segment is holding the maximum share (53.02%) of the market. Notably, this trend of dominance is likely to remain unchanged during the forecast period. This can be attributed to the high demand of consumable...

The global filtration market, valued at USD 6.5 billion in 2025, is projected to reach USD 7.2 billion in 2026 and USD 15.0 billion by 2035, with a 8.5% CAGR during the forecast period 2026 to 2035. In last five years, over 50 biologics been approved by the FDA and close to 10,000 biologics are being evaluated across different stages of development. Notably, biopharmaceutical filtration systems are used to separate and purify these biological products, including proteins, antibodies and vaccines...

The global digital biomanufacturing market, valued at $2.4 billion in 2025, is projected to reach $2.8 billion in 2026 and $12.0 billion by 2035, representing a CAGR of 17.6% during the forecast period 2026 to 2035. In terms of type of technology, the manufacturing execution systems segment holds the highest share (nearly 35%) of the market. With respect to deployment option, the on-premises segment is dominating the market with ~70% of the market share. Iin-house developers segment captures the...

The thermoelectric generators market size is projected to grow from USD 0.86 billion in 2025 to USD 2.38 billion by 2035, representing a CAGR of 10.73% during the forecast period till 2035. The market is witnessing ample growth majorly due to the mounting demand for energy efficiency. The growing emphasis on reducing energy consumption and improving the efficiency of power systems across various industries from automotive to manufacturing are supplementing the market demand. Further, the positiv...

The global continuous bioprocessing market is valued at USD 477.8 million in 2025 and is estimated to be worth USD 886.1 million in 2035, growing at a CAGR of 6.4% during the forecast period. Given the growing incidences of chronic diseases across the globe, pharmaceutical companies are experiencing the burden of developing biopharmaceutical drugs to treat patients. The usage of continuous bioprocessing reduces manufacturing cost (by 60%), optimization of resins (by 70%) in chromatography column...

With accelerated approval from the USFDA, several industrial players are taking strategic initiatives for technological innovations that help to explore more applications autologous cell therapies beyond cancer and autoimmune diseases. For instance, in November 2024, Nature Cell (a Korean biotechnology company) announced the success of autologous adipose stem cells that are delivered into spinal cavity of patient to treat Parkinson’s disease. This therapy has been developed by Japan Angel Stem...

The automatic aseptic sampling market, valued at USD 157 million in 2025, is projected to reach USD 191 million in 2026 and USD 913 million by 2035, with a 19% CAGR during the forecast period 2026 to 2035. Automated aseptic sampling offers several advantages, including real-time monitoring, improved productivity by up to 80%, and reduced deviation by around 65%. Additionally, the system offers diverse applications for lab automation, including analyte monitoring, bioprocessing, fraction collecti...

The global allogeneic cell therapy market valued at USD 50.0 million in 2025, is projected to grow to USD 52.4 million in 2026 and USD 1,629.6 million by 2035, representing a CAGR of 46.5% during the forecast period 2026 to 2035. Over the past few years, a number of allogeneic cell therapies targeting a myriad of disorders, such as hematological malignancies and neurological disorders have received approval from various regulatory authorities, globally. In December 2022, the European Commission...

The global medical drones market, valued at USD 708 million in 2025, is projected to reach USD 793 million in 2026 and USD 2,608 million by 2035, with a 14.1% CAGR during the forecast period 2026 to 2035. Drones are becoming indispensable in the healthcare industry, serving various functions, such as delivering drugs, medical kits, vaccines, organs and surgical equipment. The heightened interest in the medical drones market can be validated by the fact that, in the last four years, more than USD...

The global single-use consumables market, valued at USD 3.42 billion in 2024, is projected to reach USD 4.02 billion in 2025 and USD 15.19 billion by 2035, representing a CAGR of 14.2% during the forecast period. The global market is categorized across different types of materials, such as metals, plastics, glass, biodegradable materials and other materials. Currently, plastics segment holds the highest share (65%) of the market. Based on the end user, the global market is segmented into biophar...

The telerehabilitation systems market is estimated to grow from USD 608.21 million in 2024 to reach USD 710.52 million in 2025 and USD 2,542.13 million by 2035, representing a higher CAGR of 13.6% during the forecast period. The telerehabilitation systems market analysis also features the likely distribution of the current and forecasted opportunity within the nutraceutical testing services domain across various segments, such as type of product, type of therapy, type of service, application are...

The global super generics market, valued at USD 90.9 billion in 2025, is projected to reach USD 98.8 billion in 2026 and USD 199.5 billion by 2035, with a 8.12% CAGR during the forecast period 2026 to 2035. In the pharmaceutical industry, super generic drugs represent improved versions of an original pharmaceutical drug that have lost their patent exclusivity. These modified pharmacological interventions are commonly referred to as complex generics / value added generics. These enhanced versi...

The smart airport market size is projected to grow from USD 8.59 billion in 2025 to USD 22.71 billion by 2035, representing a CAGR of 10.21%, during the forecast period till 2035. The market is fragmented into multiple types of enterprise namely large and small and medium enterprise. Currently, the large enterprise segment is anticipated to dominate with 60.34% of the market share of smart airport solutions. However, small and medium enterprise segments are expected to witness a relatively highe...

The next generation sequencing market size, valued at USD 8.6 billion in 2025, is projected to reach USD 9.8 billion in 2026 and USD 46.5 billion by 2035, with a 18.9% CAGR during the forecast period 2026 to 2035. The market research report presents an in-depth analysis of the various next-generation sequencing companies across different segments. Key Next-generation Sequencing Technology providers profiled in the report include Illumina, MGI Tech, Oxford Nanopore Technologies, Pacific Bioscienc...

The global single use assemblies market, valued at USD 13.61 billion in 2024, is projected to reach USD 16.61 billion in 2025 and USD 81.53 billion by 2035, representing a CAGR of 17.2% during the forecast period. One of the key objectives of the single use assemblies market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. Based on the type of product, the global market is segmented into bag assemblies (2D bag assemblies...

The global drug screening market, valued at USD 8.53 billion in 2024, is projected to reach USD 10.2 billion in 2025 and USD 37.31 billion by 2035, representing a CAGR of 14.1% during the forecast period. One of the key objectives of the drug screening market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. According to the drug screening market analysis, presently the product segment holds more than 55% of the market sha...

The global medical spa market, valued at USD 20.38 billion in 2024, is projected to reach USD 23.71 billion in 2025 and USD 82.10 billion by 2035, representing a CAGR of 13.2% during the forecast period. Considering the emerging market, various industrial players are driving innovations and leveraging advanced technologies to facilitate the development of medical aesthetics combined with medical spa procedures. One of the key objectives of the medical spa market report was to estimate the curren...